Evidence map›Paper›PMID 36566342›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2023

Separation of long-stranded RNAs by RP-HPLC using an octadecyl-based column with super-wide pores.

Tomomi Kuwayama, Makoto Ozaki, Motoshi Shimotsuma, Tsunehisa Hirose

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Removal of dsRNA byproducts using affinity chromatography.Molecular therapy. Nucleic acids · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tomomi Kuwayama *Nacalai Tesque, Inc., Ishibashi Kaide-Cho, Muko, Kyoto, 617-0004, Japan.
Makoto Ozaki *Nacalai Tesque, Inc., Ishibashi Kaide-Cho, Muko, Kyoto, 617-0004, Japan.
Motoshi ShimotsumaNacalai Tesque, Inc., Ishibashi Kaide-Cho, Muko, Kyoto, 617-0004, Japan.
Tsunehisa HiroseNacalai Tesque, Inc., Ishibashi Kaide-Cho, Muko, Kyoto, 617-0004, Japan. hirose-t@nacalai.co.jp.ORCID http://orcid.org/0000-0002-4047-939X
Hirose Electric (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Messenger ribonucleic acids (mRNAs) have been used in vaccines for various diseases and are attracting attention as a new pharmaceutical paradigm. The purification of mRNAs is necessary because various impurities, such as template DNAs and transcription enzymes, remain in the crude product after mRNA synthesis. Among the various purification methods, reversed-phase high-performance liquid chromatography (RP-HPLC) is currently attracting attention. Herein, we optimized the pore size of the packing materials, the mobile phase composition, and the temperature of the process; we also evaluated changes in the separation patterns of RNA strands of various lengths via RP-HPLC. Additionally, single-stranded (50-1000 nucleotides in length) and double-stranded (80-500 base pairs in length) RNAs were separated while their non-denatured states were maintained by performing the analysis at 60 °C using triethylammonium acetate as the mobile phase and octadecyl-based RNA-RP1 with super-wide pores (> 30 nm) as the column. Furthermore, impurities in a long-stranded RNA of several thousand nucleotides synthesized by in vitro transcription were successfully separated using an RNA-RP1 column. The columns used in this study are expected to separate various RNA strands and the impurities contained in them.

Indexed as

DNARNAChromatography, High Pressure LiquidNucleotidesRNA, MessengerDNANucleotidesRNARNA, MessengerHigh-performance liquid chromatography (HPLC)Octadecyl-based columnRibonucleic acid (RNA)Separation and purificationSuper-wide pore

Identifiers

PMID36566342
PMCPMC9789886
OpenAlexW4312204909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.